Laboratorio Reig Jofre, S.A. (BME:RJF)

Market Cap	212.96M
Revenue (ttm)	338.90M
Net Income (ttm)	10.47M
Shares Out	80.06M
EPS (ttm)	n/a
PE Ratio	20.35
Forward PE	14.78
Dividend	0.04 (1.50%)
Ex-Dividend Date	May 17, 2024

Volume	25,860
Average Volume	29,019
Open	2.640
Previous Close	2.660
Day's Range	2.620 - 2.710
52-Week Range	2.440 - 3.380
Beta	0.91
RSI	52.48
Earnings Date	May 9, 2025

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics. The company offers nutritional and parapharmacy products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 1,331
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: RJF

Financial Performance

In 2024, Laboratorio Reig Jofre's revenue was 338.90 million, an increase of 6.59% compared to the previous year's 317.95 million. Earnings were 10.47 million, an increase of 11.27%.